Journal
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY
Volume 25, Issue 4-5, Pages 337-341Publisher
SPRINGER
DOI: 10.1007/s10974-004-6060-7
Keywords
myosin; blebbistatin; inhibitors
Categories
Funding
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004234, Z01HL004234] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Blebbistatin is a small molecule inhibitor discovered in a screen for inhibitors of nonmuscle myosin IIA. We have examined the specificity and potency of the drug by assaying its effects on the actin-activated MgATPase assay of diverse members of the myosin superfamily. Blebbistatin potently inhibits several striated muscle myosins as well as vertebrate nonmuscle myosin IIA and IIB with IC50 values ranging from 0.5 to 5 muM. Interestingly, smooth muscle which is highly homologous to vertebrate nonmuscle myosin is only poorly inhibited (IC50=80 muM). The drug potently inhibits Dictyostelium myosin II, but poorly inhibits Acanthamoeba myosin II. Blebbistatin did not inhibit representative myosin superfamily members from classes I, V, and X.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available